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Abstract  
BACKGROUND: Asthma is characterized by airway inflammation which can be reversible.  
AIM: Investigation the importance of eosinophils, ECP and IL-5 in asthmatics versus patients with 
obstructive bronchitis and healthy subjects. We investigated the values before and after the 
treatment in asthmatics. 
MATERIAL AND METHODS: We studied 77 subjects divided in three groups as follows: 1) asthma 
patients; 2) patients with obstructive bronchitis and 3) control group of healthy subjects. In all the 
subjects there were determined: Total number of eosinophils (Eo), eosinophilic cationic protein 
(ECP), Interleukin 5 (IL-5) and allergy tests.  
RESULTS: The total number of eosinophils was significantly increased in the group of asthma 
patients versus second and third group. We found that the presence of ECP demonstrate an 
ongoing inflammation, with or without clinical symptoms of asthma patients. There was significant 
difference between the values of ECP of asthma patients versus second and third group. Our 
results have shown that IL-5 was significantly increased versus second group and controls (p < 
0.01). We also found the decrease of the values of inflammatory markers after the treatment with 
corticosteroids.  
CONCLUSIONS: Eosinophils, ECP and IL-5 could be useful markers for selecting allergic patients 
and could be the monitors of treatment effects. 
 
 
 
 
 
 
 
Introduction 
 
The allergy is called an epidemic of the 
twentieth century. The allergic diseases are among 
the most common diseases in European countries 
and cover 15-30% of the (general) population. Asthma 
represents a possible disease of the entire human 
population and it is a rising illness. Worldwide about 
2% of the total population suffers from asthma. 
Industrially developed countries: 2-10%; USA: 
approximately 18 million asthmatics, out of which 
about 4,8 are children; Russia: approximately 20 
million inhabitants suffer from asthma; Republic of 
Macedonia: about 5% from the population (above 100 
000). 
The morbidity and the mortality caused by 
asthma continue to grow, even in the present, in times 
of advanced scientific researches and modern 
therapeutic treatment [1-5]. 
 
Definition of asthma 
Asthma is a heterogeneous disease, usually 
characterized by chronic airway inflammation. It is 
defined by the history of respiratory symptoms such 
as wheeze, shortness of breath, chest tightness and 
cough that vary over time and in intensity, together 
with variable expiratory airflow limitation. Both 
symptoms and airflow limitation characteristically vary 
over time and in intensity. These variations are often 
triggered by factors such as exercise, allergen or 
irritant exposure, change in weather, or viral 
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respiratory infections. Symptoms and airflow limitation 
may resolve spontaneously or in response to 
medication, and may sometimes be absent for weeks 
or months at a time. On the other hand, patients can 
experience episodic flare-ups (exacerbations) of 
asthma that may be life-threatening and carry a 
significant burden to patients and the community [1]. 
 
Ethyology of asthma 
The most common asthmatics triggers are as 
follows: allergic (house dust, pollen, moled spores, 
fungi, animals, insects etc.); environmental factors 
(cold, moisture, smog etc.); professional irritants; 
respiratory infections; food and food additives; 
medicines (antibiotic, aspirin, analgesic etc.); 
hyperventilation and physical effort; vasculitis; 
parasitic infections and some other less expressed 
triggers. 
There is also a genetic predisposition defined 
as atopy. If there is not atopic parent 15% of their 
children could be affected. If there is one atopic parent 
40-50% of their children could be affected. If both 
parents are atopic 75% of their children could be 
affected. 
Based on the ethiology asthma could be [1, 4, 
5]: atopic, extrinsic - the exposure to certain allergens 
leads to inflammation of the airways, which results in 
asthmatic attacks; and nonatopic, intrinsic - an 
allergen is not identified. 
 
Pathogenesis of asthma 
Pulmonary inflammation is characterized by: 
oedema, mucosal and vascular permeability, mucus 
secretion, reduction in mucociliary clearance, 
epithelial damage, subepithelial fibrosis, increased 
neuron sensitivity and cells infiltration. 
 
Figure 1: Immunological reaction 
 
T-cells are central to the immune response as 
regulators and effectors of the immune function. After 
chronic exposure to antigen, two subpopulations of T-
cells may be identified as: T-helper1 (Th1) and T-
helper2 (Th2).There is common participation with: B-
lymphocyte cells, mast cells, eosinophils and 
macrophages. The atopic allergy is type-2 (Th2) 
hypersensitivity to antigen with genetic origin and 
environmental impact. 
Cytokines are low-molecular proteins which 
are produced by almost all eukaryotic cells and they 
are acting through specific “cell-surface” receptors. 
Cytokines have multiple activities, presented in the 
cytokine cascade. We can present the immunological 
reaction and cytokine cascade on Figure 1 [6]. 
The inflammatory cells and various mediators 
cause damage of the airway (respiratory) epithelium, 
inducing bronchial hyperreactivity (Fig. 2) [7]. 
 
 
Figure 2: Inflammation in airways 
 
The bronchial obstruction is manifested in 
three stages [8]: 
1) Bronchoconstriction (early stage) occurs 
10-15 minutes after a spasmogenic contact with 
trigger stimulus. The stage is an early reaction with 
short term, with increased resistance in airways and it 
is reversible. 
2) Second stage is bronchial obstruction with 
an inflammatory oedema of the bronchi, on which a 
mucus secret is complemented (related). It occurs 5-8 
hours after the trigger contact; lasts a few days and it 
is sensitive to therapy with corticosteroids. 
3) Subacute or chronic inflammation is severe 
inflammation expressed with infiltration and 
eosinophilic invasion. 
Eosinophils are significant effector cells, 
involved into the late and chronic stage of the allergic 
inflammatory response. The tissue eosinophilia is 
mainly a result of the cured IL-5 of the allergen 
specific T-Ly [9-11]. 
According to literature, the values of ECP are 
[11, 12]: higher among atopic people 48-72 hours 
after allergenic exposition; higher during the pollen 
season; correlate with Eosinophils (Eo); correlate with 
the severity of asthma; more useful for chronic 
inflammation; are not specific for asthma; higher 
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values at rhinitis or eczema (non-asthmatic atopic 
people); and significant for monitoring of the 
treatment. 
Interleukin 5 (IL-5) has the central part in the 
maturation of eosinophils (Eo), with their release, 
activation, extension of survival and degranulation [10, 
11]. 
The aim of our study was to show the 
importance of inflammation as key of asthma; to 
determine some parameters as markers of the 
inflammatory process; to show the significance of Eo 
and ECP, while measuring the level of a specific type 
of inflammation; to make an investigation of ECP as a 
marker of antigen exposition; to make an investigation 
if the value of ECP could be an indication of the effect 
of the treatment and to determine the significance of 
IL-5 in the inflammatory chain and the evolution of 
asthma. 
 
 
Material and Methods 
 
We have investigated 77 subjects at the age 
among 23 and 79 years old. At each subject, there 
were complete examinations made for proper 
diagnosis and categorization.  
 
Groups of the patients 
1
st
 group: 44 patients with asthma (15 with 
intrinsic asthma and 29 with extrinsic asthma); 
2
nd
 group: 21 patients with chronic obstructive 
bronchitis; 
3
rd
 group: 12 healthy subjects. 
The classification was according to the actual 
version of the GINA guidelines (Global Initiative of 
Asthma) [1] and actual version of Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) [13]. 
In all subjects we were investigated: total 
number of eosinophils (Eo); eosinophilic cationic 
protein (ECP); Interleukin 5 (IL-5) and allergy skin 
tests. 
 
Statistical analysis 
The results were statistically analysed 
according to the ANOVA test, Kruskal-Wallis test, 
Wilcoxon and Man Whithey test. The significances 
value were taken p<0.05 and a highly significant p < 
0.01. 
 
 
Results 
 
In our study there is significant deference 
between the average values of Eo in asthmatics 
versus average values of Eo in patient with 
obstructive bronchitis and healthy controls (Fig. 3). 
 
Figure 3: Average values of the total number of Eo among the 
examined groups. ANOVA: Fx = 13.099, DF = 2, p < 0.01 
 
 
Total number of eosinophils was significantly 
increased in patient with intrinsic versus extrinsic 
asthma (Fig. 4). 
 
Figure 4: Comparison of Eo values between intrinsic and extrinsic 
asthma. Mann-Whithey test: p < 0.01 
 
Average values of ECP were significantly 
increased in asthmatics versus ECP in patient with 
obstructive bronchitis and group of healthy controls 
(Fig. 5). 
 
Figure 5: Average value of ECP. Kruskal Wallisov test Hi = 16.579, 
DF = 2, p < 0.01 
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Values of ECP were significantly increased in 
patients with intrinsic versus extrinsic asthma (Fig. 6). 
 
Figure 6: Comparison of ECP values between intrinsic and extrinsic 
asthma. Mann-Whithey test: p < 0.01 
 
Average values of IL-5 were significantly 
increased in asthmatics versus IL-5 in the group of 
patients with obstructive bronchitis and group of 
healthy controls (Fig. 7). 
 
Figure 7: Average values of IL-5. Kruskal Wallisov test Hi = 21.958, 
DF = 2, p < 0.01 
 
Values of IL-5 were significantly increased in 
patients with intrinsic versus extrinsic asthma (Fig. 8). 
 
Figure 8: Comparison of IL-5 values between intrinsic and extrinsic 
asthma. Mann-Whithey test: p < 0.05 
 
The values of ECP in patients with asthma 
were significantly decreased after treatment with 
corticosteroids (Fig. 9). 
 
 
Figure 9: Values of ECP in patients with asthma before and the 
after treatment with corticosteroids. Wilcoxon test p < 0.01 
The values of IL-5 in patients with asthma 
were significantly decreased after treatment with 
corticosteroids (Fig. 10). 
 
Graphic 8: Values of IL-5 in patients with asthma before and the 
after treatment with corticosteroids. Wilcoxon test p<0.01 
 
 
Discussion  
 
Activated Eo in asthmatics delivered 
granulated proteins, like ECP detected in bronchial 
biopsies, BAL, sputum and blood (De Blay F. et al) 
[16]. According to our results there is significant 
deference between the average values of Eo and 
ECP in asthmatics versus average values in patient 
with bronchitis and healthy controls. Bousquet in a 
study tells that in cases with COPD the values of ECP 
are not raised [14]. 
We noticed significant correlation between the 
values of ECP and skin allergy tests as it is known in 
literature. Our results did not show significant 
correlation between ECP, FEV1 and symptom score. 
According Ronchi serum ECP values were increased 
in asthmatics versus healthy controls, but there was 
not the correlation with clinical symptoms and 
pulmonary function [19]. In our results we found 
positive correlation between ECP and total number of 
Eo. The study of Vaterlla says that the value of ECP is 
significantly increased during pollen season and the 
changes of ECP significant correlated with the 
changes of total number of Eo [20]. Increased values 
of ECP in sera could suggest asthma, but they are not 
specific for asthma as ECP could be increased in non-
asthmatic patients with rhinitis, eczema, urticarial etc. 
There is significant deference between the 
values of IL-5 in asthmatics versus group of patients 
with bronchitis and healthy controls. IL-5 suggests 
inflammation in asthma [17, 18]. There is positive 
correlation between values of IL-5 and allergy tests. 
Japanese authors in their study concluded that the 
production of IL-5 is higher in asthmatics then in 
healthy subjects as follows: atopic asthma – 37.6 ± 
7.1 pg/ml; non-atopic asthma – 25.7 ± 5.5 pg/ml and 
halthy subjects – 3.0 ± 0.4 pg/ml [22]. There is not 
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fowned positive correlation between the values of IL-5 
and symptom score. The explination could be in the 
opinion that IL-5 is cytokine of late phase of the 
reponse and it is not detectable very soon after 
antigen provocation.  
The values of ECP and IL-5 have tendetion of 
decrease after corticosteroid therapy. In literture there 
are several studies according which anty-inflammatory 
therapy decrease the values of the markers as ECP 
and IL-5. 
In conclusion, the investigations that were 
made, confirm the concept that asthma is a chronic 
inflammatory disease. Determining and 
measurements of the markers of inflammation 
contributes to the diagnosis of asthma, monitoring the 
course of disease and contribute in the proper 
treatment of the asthmatic patients. 
There is significant difference of the values of 
the eosinophils in asthmatics versus patients with 
bronchitis and healthy subjects. Total number of 
eosinophils versus patients with obstructive bronchitis 
is not different as in healthy controls. 
There are significantly higher values of ECP 
in asthmatics versus patients with obstructive 
bronchitis and healthy subjects. Correlation between 
ECP and FEV1 and ECP and symptom score were 
not found. ECP could be higher in non-asthmatic 
atopic patients like patients with rhinitis, egzema, 
urticaria. There is significance in average values of IL-
5 in asthmatics versus values of IL-5 in patients with 
obstructive bronchitis and healthy subjects. We found 
positive correlation between Eo and ECP and Eo, 
ECP and IL-5 with allergy tests. Values of ECP and 
IL-5 decreased after therapy with corticosteroids.  
Values of markers of inflammation have their 
importance together with other tests ad criteria for 
proper diagnosis and treatment of asthma. 
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